BC

Benedict Cross

Chief Technology Officer and Head of Platform

PhoreMost Ltd

Cambridge, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
PhoreMost Ltd
Industry
biotechnology
Employees
48.0
Seniority
C suite
Annual Revenue
1000000.0
Total Funding
76263124.0
Latest Funding
Series B

Technologies

Outlook Typekit Mobile Friendly Apache

Keywords

drug discovery development biotechnology oncology target discovery platform technology development targeted protein degradation siteseeker glueseeker novel therapeutics e3 ligases degradation drug development bivalent degraders protacs molecular glue degraders deep learning protein structural simulation therapeutic targets pipeline development high-throughput screening phenotypic screening micro-proteins drug targets proprietary technology cancer treatments biopharmaceuticals collaborative partnerships clinical development preclinical studies therapeutic areas unmet medical needs innovative medicines selectivity & specificity functional validation disease biology human proteome real-time cell assays therapeutic insights molecular glue discovery novel drug pockets protein homeostasis proteasome machinery e1 & e2 enzymes synthetic biology drug design therapeutics innovation diagnostics & treatment disruptive technology high-risk drug targets collaboration models hospital & health care artificial intelligence information technology & services

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans